Davita Inc vs Innovative Industrial Properties Inc — how do they compare? Davita Inc trades at $178.74 (market cap $11.38B), while Innovative Industrial Properties Inc trades at $58.2 (market cap $1.67B). The key difference: Davita Inc is far larger — about 6.8× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 13.18% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | IIPR | |
|---|---|---|
Market Cap | $11.38B | $1.67B |
Sector | Health | Real Estate |
52-Week High | $240.96 | $64.67 |
52-Week Low | $103.87 | $44.58 |
Enterprise Value | $24.10B | $2.21B |
Dividend Yield | — | 13.18% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
IIPR trades at $58.22, up 1.29% on the day, with a bearish technical signal despite oversold RSI readings near 29. The stock shows mixed earnings performance, beating estimates in Q2 2026 but missing in Q1, with Q3 results pending. Revenue declined to $266 million in 2025, though net margins remain strong at 52.27%. A recent dividend of $1.90 was declared, payable in July 2026. Analyst sentiment is cautious with a Hold-heavy consensus, while institutional activity includes a significant position increase by Arrowstreet Capital.
The outlook for IIPR balances high profitability and a solid balance sheet against revenue headwinds and tenant distress risks. Investment appeal lies in its attractive valuation (P/E of 13.05, P/B below 1) and high dividend yield, but caution is warranted due to declining cash flow, bearish technical trends, and sector-specific regulatory uncertainties. The stock may offer value for income-focused investors if operational stability improves.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →